VAL vs VRTX
As of Sep 20, 2026, Valaris (VAL) scores 4.6/10 and Vertex Pharmaceuticals Inc / MA (VRTX) 5.3/10 on AlphaStocks' five-model composite, so VRTX scores higher. VRTX trades 50% above its model fair value.
VAL
Valaris Ltd
4.6
Weak
$83.77
VRTX
VERTEX PHARMACEUTICALS INC / MA
5.3
Consider Buy
$508.29
VAL vs VRTX: Which is the Better Investment?
Valaris Ltd (VAL) scores 4.6/10 while VERTEX PHARMACEUTICALS INC / MA (VRTX) scores 5.3/10 on AlphaStocks' composite model. VERTEX PHARMACEUTICALS INC / MA has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | VAL | VRTX |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 4.6/10 | 5.3/10▲ |
| Rating | Weak | Consider Buy▲ |
| Price | $83.77 | $508.29 |
| P/E Ratio | 6.0 | — |
| ROE | 35.0% | — |
| Market Cap | $6B | $129B |
| Fair Value | — | $339.42 |
| Dividend Yield | — | — |
| Sector Rank | #37 of 80 | #99 of 168▲ |
| Model Verdicts | ||
| Piotroski | Strong▲ | Attractive |
| Buffett | Attractive | Attractive |
| Graham | Neutral▲ | Caution |
| Lynch | Neutral▲ | Limited Data |
| Greenblatt | Attractive▲ | Limited Data |
Related comparisons
VAL vs VRTX: Which Stock Scores Higher?
Valaris Ltd (VAL) is in the Energy sector; VERTEX PHARMACEUTICALS INC / MA (VRTX) is in Health Care. VRTX currently leads with a composite score of 5.3/10 (Consider Buy) compared to VAL's 4.6/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer